Inaugural Digital Hospital of the Future 2015 set to gather leading healthcare and technology providers to reshape healthcare delivery in Australia.

More than 20 distinguished speakers and up to 200 high level health professionals will convene at the inaugural Digital Hospital of the Future, Australia 2015 this November to network and develop actionable strategies that can realize the benefits of a digital hospital from both a clinical and patient perspective. 

The Visionary Keynote Speaker will be The Hon. Jillian Skinner, NSW Minister for Health, who will be speaking on “Reshaping healthcare delivery in Australia: the evolving role of hospitals in the health ecosystem”.  The Hon. Jillian Skinner has more experience in the health field than any other politician in Australia, having served as Shadow Minister for Health from 1995 and Minister for Health since 2011.

Organized by the pre-eminent global business leadership institution, Clariden Global , this conference is Australia’s first-of-its-kind event that delves into how digital technology can be maximized to create exceptional patient experience and improve healthcare efficiency. The conference will take place on 25 – 27 November 2015 at the InterContinental Sydney.

Where hospitals are concerned, the concept of ‘digital hospital’ has started to gain traction amongst healthcare facilities providers, as these organizations begin to recognize the benefits of process digitalization for greater productivity, efficiency and organization.

"If we consider the accelerating rate of change in healthcare, the challenges may seem overwhelming, but the future looks bright, " said Lucas Guo, Conference Director, Clariden Global. 

"Be in the midst of the healthcare IT leaders of today, who are doing more than just talking a good digital game. They are fundamentally changing the way technology is used for care delivery. The digital hospital is as much a way of thinking about the future of healthcare as it is about technology"

The conference will feature exclusive co-present sessions that will highlight the value of vendor partnerships and offer an insight-oriented agenda to cover the entire value chain. This event also serves a platform for healthcare professionals to discover emerging trends in the industry and learn about new technological solutions to stay relevant in the years to come.

Post-conference will see a highly interactive workshop co-run by health IT leaders from Telstra and Microsoft and Site Tours to leading ICT-driven hospitals, The Chris O'Brien Lifehouse and Macquarie University Hospital, exclusively conducted by top senior management.

Visit the Digital Hospital website  to view the full agenda, speakers' profile and register. 

Clariden Global is the pre-eminent and influential global business leadership institution. Today, Clariden Global hosts more than 100 global executive education and major conference events around the world in nine countries, including Singapore, London, Australia, China, Malaysia, Indonesia, Hong Kong, South Africa and UAE. Clariden Global partners with renowned thought leaders and global institutions for influential events around the world. Our mission is to provide global knowledge for the world business leaders. To see our credentials & global engagement, please visit us at http://www.claridenglobal.com

Eileen Tay,

Clariden Global

M: +65 6716 9984

E: eileen.tay@claridenglobal.com 

Over the years, Frost & Sullivan’s Healthcare Practice has recognized distinguished companies and individuals for their significant achievements and seamless contribution to the country’s healthcare industry. Continuing its efforts, Frost & Sullivan successfully hosted the seventh edition of its India Healthcare Excellence Awards on October 9, 2015 at Hyatt Regency, Mumbai.

The awards banquet, attended by the prominent figures in the healthcare industry celebrated the success of the winning enterprises. Awarded for their growth strategies, due diligence in development and innovation, 

showcasing best practices adoption and host of other critical factors, the 25 award recipients at the 7 Healthcare Excellence Awards represented the best-in-class of the healthcare business.

On the occasion, Sandeep Sinha, Vice President, Healthcare Practice, South Asia and Middle East, Frost & Sullivan said, “The award recipients of this year’s Healthcare Excellence Awards represent a mix of established enterprises and innovative start-ups, who with their capability to revolutionize the healthcare industry, are expected to bring in groundbreaking innovations and novel practices in India’s healthcare system. Frost & Sullivan is proud to recognize their efforts and encourage them in their future endeavor.”

This year, the awards were presented across four major award categories: Pharmaceuticals and Biotechnology, Healthcare Delivery Services, Medical Technologies, and Research-based Awards. Following a rigorous process of selection, the awards jury comprising of eminent industry experts, key opinion leaders,

and visionary innovators, rated nominees across eight to 10 parameters, backed by the research data from Frost & Sullivan and their market knowledge and domain expertise. Besides these categories, there were two Special Awards conferred by Frost & Sullivan to exemplary individuals who have contributed significantly to the healthcare industry for its advancement and furtherance.

th Annual India Healthcare Excellence Awards 2015, consisted the following eminent  Dr. Amit Varma, Founder and Managing Partner — Quadria Capital Investment Advisors Private Limited

• Dr. Ashutosh Raghuvanshi, Managing Director, Vice Chairman and Group CEO — Narayana Health
• Badhri Iyengar, Regional Director — Boston Scientific, Middle East, Africa, and Turkey
• Daljit Singh, President — Fortis Healthcare Limited; Chairman — Malar Hospitals; Director on the Board of
• Gaurav Malik, Managing Director — Olympus Capital Asia
• Gautam Khanna, Chief Executive Officer — PD Hinduja National Hospital & MRC
• Dr. Praneet Kumar, Consultant, Hospitals and Health Services, Japan Hospital Fellow — International
• Sudhir Mishra, Chairman and Managing Partner — Trust Legal Advocates and Consultants
• Swami D. Swaminathan, Executive Chairman — Manipal Health Enterprises; Chairman — Manipal
• Vishal Bali, Asia Head, Healthcare — TPG Growth; Chairman — Medwell Ventures

The banquet was supported by the following Media Partners – Chronicle Pharmabiz, Health Biz India, Healthcare Executive, Hospital & Healthcare Management, Medical Device Asia, and Pharma Bio World  A G l o b a l G r o w t h P a r t n e r s h i p C o m p a n y

The Frost & Sullivan’s 7th Annual India Healthcare Excellence Awards 2015 recipients are:

Award Titles and Categories Award Recipients

Nephrology Pharmaceutical Company of The Year Dr. Reddy’s Laboratories Ltd.

Disease Awareness Campaign of the Year — Pharmaceutical 

Company Abbott

Innovative Marketing Campaign of the Year —Pharmaceutical Company Abbott 

Vision Care Pharmaceutical Company of the Year Allergan India Pvt. Ltd.

Assisted Living Service Provider Company of the Year Kshetra by Heritage Elder Care Services (P) 

Diabetes Management Service Provider Company of the Year Lifespan Diabetes & Cardiometabolic Clinic Ayurveda Medicine Service Provider Company of the Year AYURVEDALAYA Comprehensive Cardiology Service Provider Company of the Year Narayana Health Comprehensive Neurosciences Service Provider Company of the Year Institute of Neurosciences Kolkata Comprehensive Neurosciences Service Provider Company of the Year Fortis Hospitals, Noida

Comprehensive Neurosciences Service Provider Company of the Year Apollo Hospitals, Chennai

Comprehensive Gastroenterology Service Provider Company of the Year Gem Hospital & Research Centre, Coimbatore

Online Medical Opinion Service Provider Company of the Year MediAngels.com 

Medical Technology Company of the Year Philips Healthcare

Emerging Medical Technology Company of the Year Meril Life Sciences

Clinician Skill Enhancement Company of the Year Johnson & Johnson Medical India

 

 A G l o b a l G r o w t h P a r t n e r s h i p C o m p a n y

Integrated Emergency Medical Services Enabling Technology 

Home Medical Care Services Company of the Year Portea Medical 

Medical Imaging Technology Innovation Leadership Ricoh India Ltd.

Audiology Service Provider Company of the Year Bengal Speech & Hearing Pvt. Ltd.

 

 

 

If you wish to know more about the Awards program, please contact Ravinder Kaur / Priya George at ravinder.kaur@frost.com  / priyag@frost.com  or E-mail at indiahcawards@frost.com . For more details, visit Frost & Sullivan,visit www.frost.com/hcawards2015 

Frost & Sullivan, a Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's 

 

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation, and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics, and emerging economies?

 

contact Us: Start the discussion

 

Ravinder Kaur, Corporate Communications – South Asia

M: +91 99401 41714; P: +91 44 6681 4413

E: ravinder.kaur@frost.com

Priya George, Corporate Communications – South Asia

M: +91 98403 55432; P: +91 44 6681 4414

E: priyag@frost.com

http://ww2.frost.com  

Twitter: @Frost_MENASA (#FSHCawards)

• Region’s hallmark event for Asia’s medical and health care sector returns to Singapore for 11th edition
• Exhibition well-positioned to meet of the next wave of healthcare modernisation

Following on its successful growth path since its inception in 1997, the region’s most established platform for the medical and health care sectors – MEDICAL FAIR ASIA – will see its most impressive line-up ever of prominent medical and health care players from around the world from 31 Aug to 2 Sep 2016.

Reinforcing the global appeal and market relevance of the trade fair, MEDICAL FAIR ASIA 2016 is expected to attract strong participation from some 1,000 exhibitors from about 45 countries including 20 national pavilions and country groups. This is a marked increase from 2014,

which saw MEDICAL FAIR ASIA welcome a stellar list of 700 exhibitors from 38 countries. Visitor attendance is also expected to increase by 50% from the last edition in 2014, with 15,000 trade visitors coming from across ASEAN and the Asia Pacific region.

Co-located with MEDICAL MANUFACTURING ASIA 2016, a trade fair focusing on the medical technology and medical manufacturing sector and jointly organised by Messe Dῡsseldorf Asia and the Singapore Precision Engineering & Tooling Association (SPETA), the synergistic qualities of both trade fairs will present a comprehensive one-stop event for trade professionals sourcing for solutions across the value chain.

Focused on equipment and supplies for the hospital, diagnostic,pharmaceutical, medical and rehabilitation sectors, MEDICAL FAIR ASIA 2016 is well positioned to be the No.1 procurement stage for industry professionals to experience new and innovative technologies, solutions, products and services – many of which will be launched in Asia for the first time – but will also align its theme with current and future demographic trends, challenges and notably, – the next wave of healthcare modernisation.

exchange of the latest innovations and technologies, MEDICAL FAIR ASIA continues to raise the overall capabilities and spur the growth of the region’s medical and healthcare sectors to meet the changing demands in both the public and private sectors.

Driven by rapid urbanization, increased population and increased longevity, the focus of medical and healthcare services within the region is turning to disease management and healthcare provision for the elderly, as well as preventive healthcare for the general population. Coupled with the launch of the ASEAN Economic Community (AEC) and the rise in affluence, the demand for quality medical services by both local and international patients within the region is rapidly increasing, opening up a wealth of opportunities.

As the region’s medical and healthcare sector continues on the robust growth, MEDICAL FAIR ASIA will continue to be the preferred strategic business platform for region’s medical and healthcare industries.

With exhibition spaces filling fast, interested exhibitors are encouraged to submit their space booking forms for MEDICAL FAIR ASIA 2016 at the earliest opportunity. For more information on the trade fair, please visit www.medicalfair-asia.com

Maria Wesson 

Tel: +65 6332 9651 

Email: maria@mda.com.sg

 

Daphne Yeo

Tel: +65 6332 9682

Email: daphne@mda.com.sg 

MDA is a subsidiary of Messe Düsseldorf in Germany, one of the world’s leading trade fair organizers, responsible for organizing more than 20 global No. 1 exhibitions in industries including plastics, printing and packaging, and medical and health care – specifically K,drupa, interpack, MEDICA, COMPAMED and A+A held in Düsseldorf, Germany. Since 1995,

MDA’s portfolio of trade fairs in Southeast Asia includes: for the plastics and rubber sectors in Thailand (T-PLAS ), Vietnam (PLASTICS & RUBBER VIETNAM ) and Indonesia (INDOPLAS ), the printing and packaging sectors in Thailand (PACK PRINT INTERNATIONAL ) and Indonesia (INDOPACK  and INDOPRINT ), the wire, cable, tube and pipe sectors in Thailand (wire Southeast ASIA  and Tube Southeast ASIA ), the medical and health care industries in Thailand and Singapore (MEDICAL FAIR THAILAND,MEDICAL FAIR ASIA, MEDICAL MANUFACTURING ASIA ) the Workplace Safety & Health sectors in Singapore(OS+H ASIA ) and the metal and steel trade industries in Indonesia (indometal ). 

•  600 exhibitors from 42 countries, 15 national pavilions and country groups 
•  7,226 visitors from 59 countries, representing a 13% increase from the previous edition 

For many exhibiting companies, particularly small and medium sized firms, the resounding sentiment was the relevance of MEDICAL FAIR THAILAND as a stepping stone to penetrate the ASEAN market and to introduce their latest technologies. Mr Michael Richardson, Senior Vice President of the US firm Perry Baromedical, said: “The Southeast Asian market is becoming more significant, which is why we have come to the exhibition to increase our network and meet with existing and new distributors in the region. The number of visitors, sales leads and new contacts from Vietnam, Laos, Thailand, Indonesia, Malaysia, Philippines and Singapore

Maria Wesson 

Tel.: (65) 6332 9652 

interpack, MEDICA, COMPAMED and A+A held in Düsseldorf, Germany. Since 1995, MDA’s portfolio of trade fairs in Southeast Asia includes: for the plastics and rubber sectors in Thailand (T-PLAS ), Vietnam (PLASTICS & RUBBER VIETNAM ) and Indonesia (INDOPLAS), the printing and packaging sectors in Thailand (PACK PRINT INTERNATIONAL ) and Indonesia (INDOPACK  and INDOPRINT ), the wire, cable, tube and pipe sectors in Thailand (wire Southeast ASIA  and Tube Southeast ASIA ), the medical and health care industries in Thailand and Singapore (MEDICAL FAIR THAILAND , MEDICAL FAIR ASIA , MEDICAL MANUFACTURING ASIA ) the Workplace Safety & Health sectors in Singapore(OS+H ASIA ) and the metal and steel trade industries in Indonesia (indometal ). 

Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced that it has commenced trading on the NASDAQ Capital Market effective today.

Joel Ackerman, Chief Executive Officer commented, "Uplisting to a national exchange like NASDAQ has been a goal towards which we have been working for years.  We are pleased to reach this important milestone in the Company's history.   We expect this will provide us with increased visibility in the capital markets and access to a broader investor base, which ultimately should provide us with better access to capital."

Champions' common stock began trading under the same symbol (CSBR) at the opening of trading on August 21, 2015.

About Champions Oncology, Inc.

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs.  The Champions TumorGraft® technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen.  The Company uses this technology in conjunction with related services to offer solutions for two customer groups:  Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. Champions TumorGraft models are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions' Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.

Leading global health institutions digitize pathology workflows with Philips to enhance disease diagnoses

Pathologists across Singapore, Austria, Germany, Belgium and the UK adopt Philips Digital Pathology Solutions to drive cutting-edge diagnostics

As the number of trained pathologists decreases while the aging population and complexity of cancer is on the rise, Royal Philips announced the growing adoption of its Digital Pathology Solutions by health systems across the globe who are enhancing their operations. Through its IntelliSite Pathology Solution,* Philips enables health care organizations to reinvent the traditional histopathology workflow, enhance efficiency and productivity, and improve the confidence in making diagnosis.

Through examination of patient tissue samples, pathology plays a crucial role in the diagnosis, management and prevention of a variety of diseases, including cancer. As health care cost and quality pressures continue to mount, digital pathology can help improve the efficiency and quality of cancer diagnostics. Several high-volume and networked pathology institutions across the world have implemented the Philips digital pathology platform, which offers an integrated approach to improve workflows, enhance collaboration capabilities to speed up consults, unify patient data and enable a flexible growth path to get more information from tumor tissue.

“Modern pathology labs are coming under continued pressure to increase throughput and efficiency while improving quality,” said Russell Granzow, General Manager of Philips Digital Pathology Solutions. “As the shift towards personalized medicine requires pathology data that guides the right therapy for the right patient at the right time, Philips is driving the evolution toward digitized workflows to ensure pathologists are empowered to meet industry demand.”

• Supporting archiving in Singapore – Singapore General Hospital (SGH), the flagship hospital of the country’s public healthcare system, recently implemented the world’s largest digital pathology installation in its diagnostic laboratory. To handle its more than 50,000 pathology cases a year, SGH will leverage more than 1.6 petabytes of disk storage and 1.6 petabytes of tape archiving storage to avoid the challenges of storing glass tissue slides – like loss, breakage, degrading or manual archiving errors – and reduce the physical space needed to manage all of these records.
• Full scale installation in Belgium – The AZ Sint Jan in Brugge, Belgium completed a full-scale installation that is designed to accommodate full digital histopathology diagnosis. Recognizing that a short transitional process to digital would save a great deal in efficiency and costs, the lead pathologist Dr. Van den Berghe opted to avoid a gradual transitioning strategy by coordinating a full digital implementation to benefit from this new way of working.
• Providing remote diagnostic services across Austria – In Austria two private pathology laboratories in Hall in Tirol and St. Pölten provide diagnostic services for hospitals and private medical centers across Austria. To speed up sample diagnosis and to implement interactive consultation of experts for the patients, Dr. Soleiman is creating an international network of pathologists by transitioning to an entirely digital workflow with about 200,000 histology slides per year with the Philips IntelliSite solution.

Germany´s largest telemedicine platform goes online – The “CCS Telehealth Ostsachsen” platform is provided by a subsidiary of Dresden´s university clinic and T-Systems International. The European pilot scheme offers a broad range of possibilities in networked medical care and is intended to overcome former limitations. Incorporating digital pathology pathologists have the opportunity to analyze digitally captured tissue samples and to digitally consult a council of other specialists with the aim to improve patient diagnosis.

• Expanding teams through virtualization in the UK – Sheffield Teaching Hospitals (STH) NHS Foundation Trust will partner with Hull and East Yorkshire Hospitals NHS Trust to develop a service for remote digital reporting of pathology cases. By addressing the long standing problem of a shortage of histopathologists in the United Kingdom this unique collaboration for the UK enables the partners to offer their service to other hospitals in the Yorkshire and Humber region and beyond and facilitates access to subspecialized diagnostic histopathology service for all patients. The system is designed to scale should more sites and pathology laboratories join this collaboration.

Across the globe, leading institutions are leveraging Philips’ experience in clinical digital transformation to help pathology laboratories make that next step in workflow improvement and accelerate knowledge sharing between care providers.

* Philips IntelliSite Pathology Solution is CE marked for primary diagnostics in the EU and Health Canada. In the U.S., Philips IntelliSite Pathology Solution is cleared by FDA for diagnostic use in the evaluation of HER2 expression in breast cancer and is offered for research use (RUO).

For further information, please contact:

Hans Driessen
Philips Digital Pathology Solutions
Tel.: +31 6 10 610 417
E-mail: hans.driessen@philips.com

Steve Klink
Philips Group Communications
Tel.: +31 6 1088 8824
E-mail: steve.klink@philips.com

About Royal Philips
Royal Philips is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter .

 

Mumbai, India, August 2015 – Frost & Sullivan has acknowledged the noteworthy performances of leading organizations of the country’s healthcare industry, applauding achievements and contributions across different segments. Over the past six years, top enterprises, as well as innovative start-ups, have been felicitated at Frost & Sullivan’s India Healthcare Excellence Awards; shortlisted by some of the most prominent individuals in Indian healthcare.

At the 7th Annual India Healthcare Excellence Awards 2015, experts will select from the list of nominees across different industries and functional disciplines in the region and announce the winners under various award categories. Once again, this year, Frost & Sullivan is proud to welcome the crème-de-la-crème – experienced industry professionals, senior medical practitioners, and thought leaders of the country’s healthcare segment.

Announcing the Jury panel, Mr. Jayant Singh, Director, Healthcare Practice, Frost & Sullivan, said, “We follow a process of excellence not just for shortlisting the winners but also for selection of our jury members who chair and decide the award recipient. It gives us great pleasure to host a distinguished panel of jury members and the best in class achievers in Indian healthcare at this year’s Healthcare Excellence Awards.”

The awards program, now in its seventh year will be taking place on 9th October at Hyatt Regency, Mumbai. The awards are now a benchmark recognizing companies who have showcased their best practices through diligence and innovative business solutions; projecting these companies in the global healthcare domain.

Dr. Amit Varma, Founding Managing Partner, Quadria Capital Investment Advisors Private Limited said, “Healthcare falls within the domain of core infrastructure, investments made today will propel the growth and future of not just the industry but the country as a whole. I am delighted to be part of this endeavor to identify and recognize the present and future leaders, which will enable quality, economical and universal access to a fundamental right of life.”

Hosting the who’s who of healthcare, the awards banquet will be a platform for sharing success stories on best practices and inspirational leadership, innovative strategies in healthcare delivery, medical technologies, and other aspects of this robust, growth-intensive industry.

Mr. Daljit Singh, President, Fortis Healthcare Limited and Chairman, Malar Hospitals, said, “In today’s hyper-connected world, identifying the companies that are disruptive and create significant value for all stakeholders requires consistency, experience, and an in-depth understanding of the dynamics of the health and healthcare industries. It’s truly an honor to be part of the Frost & Sullivan jury to select the harbingers of the industry.”

The recipients for the ‘Frost & Sullivan 7th Annual India Healthcare Excellence Awards 2015’ will be recognized across the following Award titles. These also include two Special Awards.

Special Awards

Lifetime Achievement Award
Healthcare Entrepreneur of the Year

Pharmaceuticals and Biotechnology
Indian Herbal Medicine Company of the Year
Nephrology Pharmaceutical Company of the Year
Innovative Product Launch of the Year
Disease Awareness Campaign of the Year – Pharmaceutical Company
Innovative Marketing Campaign of the Year – Pharmaceutical Company
Novel Vaccine of the Year
Vision Care Pharmaceutical Company of the Year

Healthcare Delivery
Comprehensive Cosmetic Service Provider of the Year (Independent Unit)
Emerging IVF Service Provider of the Year (Independent Chain)
Assisted Living Company of the Year
Audiology Service Provider Company of the Year
Diabetes Management Service Provider Company of the Year
Ayurveda Medicine Service Provider Company of the Year
Comprehensive Cardiology Service Provider Company of the Year
Comprehensive Neurosciences Service Provider Company of the Year
Comprehensive Gastroenterology Service Provider Company of the Year
Online Medical Opinion Provider Company of the Year
Medical Tourism Services Provider Company of the Year

Medical Technologies
Medical Technology Company of the Year
Emerging Medical Technology Company of the Year
Clinician Skill Enhancement Company of the Year

The Media Partners supporting the awards this year are Chronicle Pharmabiz, Health Biz India, Healthcare executive, Hospitals & Healthcare Management, Medical Device Asia, and Pharma Bio World.

If you wish to know more about the Awards program, contact Anita Chandhoke/Priya George at achandhoke@frost.com /priyag@frost.com.

For more details, visit www.frost.com/hcawards2015

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.
•  The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.

Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation

Media Contact:
Priya George
Corporate Communications, Frost & Sullivan
M: +91 98403 55432, P: +91 44 6681 4414
E: priyag@frost.com

Anita Chandhoke
Corporate Communications, Frost & Sullivan
M: +91 9940141714, P: +91 44 6681 4413
E: achandhoke@frost.com

http://ww2.frost.com

A study published online Aug. 24 by the journal Pediatrics finds a significant decrease in the use of computed tomography (CT) scans at children's hospitals for 10 common childhood diagnoses including seizure, concussion, appendectomy and upper respiratory tract infection.

CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER.

Alternate types of imaging such as ultrasound and magnetic resonance imaging (MRI) are being used more frequently for eight of the 10 diagnoses. Study authors hypothesize the decline in CT usage may be attributable to a growing body of evidence linking ionizing radiation from CT scans to an increased risk of cancer in patients. They also point to the adoption of electronic health records, which allows for easy transfer of medical data and images and limits the need for duplicate scans.

The study, "Computed Tomography and Shifts to Alternate Imaging Modalities in Hospitalized Children," is the first of its kinds to look at CT usage across multiple hospitals and conditions.

"This study reinforces the pediatric community's commitment to think about both immediate and long term risks and benefits of our treatment," said Michelle Parker, MD, the study's lead investigator and a physician in the Division of Hospital Medicine at Cincinnati Children's Hospital Medical Center. "Minimizing potential for harm to our patients as we work to heal them should always remain a priority."

A CT scan combines a series of X-ray images taken from different angles and uses computer processing to create cross-sectional images of bones, blood vessels and soft tissues, providing more detail than conventional X-rays. CT scans, however, emit 100 to 1,000 times more ionizing radiation than conventional X-rays.

According to previously published literature, there may be one malignancy as a result of ionizing radiation among every 10,000 children exposed to CT scans. To minimize the risk of cancer in patients requiring sophisticated imaging for diagnostic purposes, when an alternate imaging modality is indicated, doctors may be shifting to MRI which uses magnetic fields or ultrasound, which uses high frequency sound waves to show internal body images in real time.

"There may still be times when a CT scan is the most appropriate imaging tool to use, however parents should be encouraged by this study which shows that physicians and hospitals are likely incorporating new evidence and adapting to provide safe medical care," said Parker.

The study used data from the Children's Hospital Association's Pediatric Health Information System (PHIS), a comparative pediatric database of clinical and resource utilization information for inpatient, ambulatory surgery emergency department and observation unit patient encounters for 45 children's hospitals. The authors looked at inpatients and observation patients for 10 specific diagnoses at 33 participating hospitals from Jan. 1, 2004 to Dec. 31, 2012. The ten diagnoses analyzed for diagnostic imaging use included seizure, ventricular shunt procedure, craniotomy, concussion, severe head trauma, appendectomy, gastroenteritis, abdominal pain, upper respiratory tract infection and ENT conditions.

In addition to Cincinnati Children's, the study included clinicians at Children's Hospital Philadelphia, Children Health in Dallas, TX and Children's Hospital Association.

About Cincinnati Children's

Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S.News and World Report's 2015 Best Children's Hospitals. It is also ranked in the top 10 for all 10 pediatric specialties, including a  #1 ranking in pulmonology and #2 in cancer and in nephrology. Cincinnati Children's, a non-profit organization, is one of the top three recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati's College of Medicine.  The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.